Advertisement

Topics

Sangamo BioSciences Company Profile

08:53 EDT 26th September 2017 | BioPortfolio

Sangamo BioSciences develops and markets novel transcription factors capable of regulating genes. The company’s powerful Universal Gene Recognition™ technology enables the engineering of a particular class of transcription factors known as zinc finger DNA-binding proteins, or ZFPs. By engineering ZFPs so that they can recognize a specific gene, Sangamo has created ZFP transcription factors that can control gene expression, and consequently, cell function.

Sangamo is commercializing its technology for applications in pharmaceutical drug discovery, human therapeutics, plant agriculture, clinical diagnostics, and industrial biotechnology. Over 20 leading pharmaceutical and biotechnology companies have used Sangamo’s Universal GeneTools™ to accelerate their understanding and control of gene function and their validation of new drug targets. In addition, Sangamo is working with Edwards Lifesciences Corporation to develop ZFP-based therapeutics for cardiovascular disease. Sangamo is also exploring novel treatments for clinical indications in cancer and infectious diseases.

Location

Point Richmond Tech Center II
501 Canal Boulevard, Suite A100
Richmond
CA
94804
United States of America

Contact

Phone: 510-970-6000
Fax: 510-236-8951
Email: info@sangamo.com


News Articles [767 Associated News Articles listed on BioPortfolio]

Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference

RICHMOND, Calif., Jan. 5, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progre...

Sangamo BioSciences Announces Presentation at 2012 Leerink Swann Global Healthcare Conference

RICHMOND, Calif., Feb. 9, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress...

Sangamo BioSciences Announces Presentation At The 2014 JMP Securities Healthcare Conference

RICHMOND, Calif., June 17, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO, will pr...

Sangamo BioSciences Announces Presentation At 31st Annual J.P. Morgan Healthcare Conference

RICHMOND, Calif., Jan. 2, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the pro...

Sangamo BioSciences Announces Presentation At The 8th Annual JMP Securities Healthcare Conference

RICHMOND, Calif., July 2, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Philip Gregory, D.Phil., Sangamo's vice president of research and CSO, will provi...

Sangamo BioSciences Announces Presentation at the 2011 UBS Global Life Sciences Conference

RICHMOND, Calif., Sept. 14, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an overview of the company's b...

Sangamo BioSciences, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 06052017] Prices from USD $350

Sangamo BioSciences, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sangamo BioSciences, Inc. Mergers Acquisitions MA, Partnerships Alliances and In...

Sangamo BioSciences, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 13062017] Prices from USD $350

Sangamo BioSciences, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sangamo BioSciences, Inc. Mergers Acquisitions MA, Partnerships Alliances and In...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Cell-mediated immunity (CMI) and in particular T cells play a critical role in the rejection of transplanted organs. Thus, in transplant recipients a life-long and individualized immunosup...

Companies [341 Associated Companies listed on BioPortfolio]

Sangamo BioSciences

Sangamo BioSciences develops and markets novel transcription factors capable of regulating genes. The company’s powerful Universal Gene Recognition™ technology enables the engineering of a particu...

Sangamo BioSciences, Inc.

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development p...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Sangamo BioSciences" on BioPortfolio

We have published hundreds of Sangamo BioSciences news stories on BioPortfolio along with dozens of Sangamo BioSciences Clinical Trials and PubMed Articles about Sangamo BioSciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sangamo BioSciences Companies in our database. You can also find out about relevant Sangamo BioSciences Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record